Skip to content

Effect of Liposomal Vitamin C on Immunity in healthy children

Effect of Liposomal Vitamin C on Immune function in healthy children (4-12 Years)

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/03/023825
Enrollment
30
Registered
2020-03-06
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Liposomal Vitamin C tablet: 100 mg twice per day for 30 days Control Intervention1: NA: NA

Sponsors

SSV Phytopharmaceuticals
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age 4-12 years Written informed consent by parents

Exclusion criteria

Exclusion criteria: 13 years or older, younger than 4 years participation in a clinical study during past 30 days intake of antimicrobial, antiviral, immunosuppressive substances, salicylic medicaments (like Aspirin) surgical intervention 3 months Prior to inclusion or planned intervention during the observation period Any respiratory or metabolic disorder

Design outcomes

Primary

MeasureTime frame
Change in The Wisconsin Upper Respiratory Symptom Survey (WURSS)â?? and Jackson score for KidsTimepoint: 30 days

Secondary

MeasureTime frame
Safety and efficacyTimepoint: 30 days

Countries

India

Contacts

Public ContactDr Yogita Gaikwad

Vakratund Hospital

yogita.vakratund@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026